Aveo Pharmaceuticals, Biogen Idec deal

Aveo said Biogen waived its exclusive option under a 2009 deal with Aveo to co-develop and commercialize outside of North America antibodies targeting epidermal growth factor receptor 3 ( EGFR3; HER...